Tag: Spinal Cord Injuries
The SciStar study is an ongoing clinical trial evaluating the safety of three sequential escalating doses of AST-OPC1 for recent cervical spinal cord injury victims. AST-OPC1 consists of neural cells known as oligodendrocyte progenitor cells, and these cells are produced from human embryonic stem cells. The second phase of the Dose Escalation Study of AST-OPC1 … Continue reading “Further Advances in Stem Cell Research for Spinal Cord Injuries”